Megestrol acetate in patients with AIDS and cachexia

Annals of Internal Medicine

Volumn 121, Issue 6, 1994, Pages 400-408

  Oster, Michelle H ^b   Enders, Sheila R ^c   Samuels, Steven J ^c   Cone, Lawrence A ^e   Hooton, Thomas M ^f   Browder, Henry P ^d   Flynn, Neil M ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GENENTECH INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University of California at Davis ^*  (United States)

^e EISENHOWER MEDICAL CENTER   (United States)

^f Eisenhower Medical Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEGESTROL ACETATE; PLACEBO;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; APPETITE; ARTICLE; CACHEXIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM FUNCTION DISORDER; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WEIGHT GAIN;

EID: 0028577535     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-121-6-199409150-00002     Document Type: Article

References (29)

1. Kotler DP, Tierney AR, Wang J, Pierson RN Jr. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr. 1989;50:444-7.
2. Kotler DP, Wang J, Pierson RN. Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr. 1985; 42:1255-65.
3. Kotler DP, Tierney AR, Brenner SK, Couture S, Wang J, Pierson RN Jr. Preservation of short-term energy balance in clinically stable patients with AIDS. Am J Clin Nutr. 1990;51:7-13.
4. Gillin JS, Shike M, Alcock N, Urmacher C, Krown S, Kurtz RC, et al. Malabsorption and mucosal abnormalities of the small intestine in the acquired immunodeficiency syndrome. Ann Intern Med. 1985;102:619-22.
5. Heise C, Dandekar S, Kumar P, Duplantier R, Donovan RM, Halsted CH. Human immunodeficiency virus infection of enterocytes and mononuclear cells in human jejunal mucosa. Gastroenterology. 1991; 100:1521-7.
6. Antony MA, Brandt LJ, Klein RS, Bernstein LH. Infectious diarrhea in patients with AIDS. Dig Dis Sci. 1988;33:1141-6.
7. Grunfeld C, Feingold KR. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med. 1992;327:329-37.
8. LoPresti JS, Fried JC, Spencer CA, Nicoloff JT. Unique alterations of thyroid hormone indices in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1989;110:970-5.
9. Kotler DP. Nutritional effects and support in the patient with acquired immunodeficiency syndrome. J Nutr. 1992;122:723-7.
10. Kotler DP, Tierney AR, Altilio D, Wang J, Pierson RN. Body mass repletion during ganciclovir treatment of cytomegalovirus infections in patients with acquired immunodeficiency syndrome. Arch Intern Med. 1989;149:901-5.
11. Tchekmedyian NS, Tait N, Moody M, Aisner J. High-dose megestrol acetate. A possible treatment for cachexia. JAMA. 1987;257:1195-8.
12. Bruera E, Macmillan K, Kuehn N, Hanson J, MacDonald RN. A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer. 1990;66:1279-82.
13. Loprinzi CL, Ellison NM, Shaid DJ, Kroop JE, Athmann LM, Dose AM, et al. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst. 1990;82:1127-32.
14. Tchekmedyian NS, Hickman M, Siau J, Greco FA, Keller J, Browder H, et al. Megestrol acetate in cancer anorexia and weight loss. Cancer. 1992;69:1268-74.
15. Loprinzi CL, Michalak JC, Schaid DJ, Mailliard JA, Athmann LM, Goldberg RM, et al. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol. 1993;11:762-7.
16. Loprinzi CL, Ellison NM, Schaid DJ, Kroop JE, Athmann LM, Dose AM, et al. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst. 1990;82:1127-32.
17. Von Roenn JH, Murphy RL, Weber KM, Williams LM, Weitzman SA. Megestrol acetate for treatment of cachexia associated with human immunodeficiency virus (HIV) infection. Ann Intern Med. 1988;109: 840-1.
18. Von Roenn JH, Murphy RL, Weber KM, Williams LM, Weitzman SA. Megestrol acetate and cachexia associated with human immunodeficiency virus (HIV) infection. Ann Intern Med. 1989;110:667-8.
19. Metropolitan Life Insurance Company. Metropolitan Height and Weight Tables. Courtesy Statistical Bulletin. 1980.
20. Gibson RS. Principles of Nutritional Assessment. New York: Oxford University Press; 1990:190-205.
21. Bock RD. Multivariate Statistical Methods in Behavioral Research. New York: McGraw-Hill; 1975:490-3.
22. SAS, version 6.04. SAS Institute Inc., 1987. Cary, North Carolina 27512-8000.
23. Nathwani D, Green ST, Heslop JM, Goldberg DJ, Kennedy DH. Beneficial response to megoestrol acetate in AIDS-related cachexia and a possible megoestrol withdrawal-associated syndrome? Acta Derm Venereol (Stockh). 1990;70:520-1.
24. Von Roenn JH, Roth E, Murphy RL, Weber KM, Williams LM, Weitzman SA. Controlled trial of megestrol acetate for the treatment of AIDS-related anorexia and cachexia [Abstract]. International Conference on AIDS. 1992;WB2392.
25. Loprinzi CL, Jensen MD, Jiang NS, Schaid DJ. Effect of megestrol acetate on the human pituitary-adrenal axis. Mayo Clin Proc. 1992;67: 1160-2.
26. Watson AD, Church DB, Emslie DR, Middleton DJ. Comparative effects of proligestone and megestrol acetate on basal plasma glucose concentrations and cortisol responses to exogenous adrenocorticotrophic hormone in cats. Res Vet Sci. 1989;47:374-6.
27. Middleton DJ, Watson AD, Howe CJ, Caterson ID. Suppression of cortisol responses to exogenous adrenocorticotrophic hormone, and the occurrence of side effects attributable to glucocorticoid excess, in cats during therapy with megestrol acetate and prednisolone. Can J Vet Res. 1987;51:60-5.
28. Henry K, Rathgaber S, Sullivan C, McCabe K. Diabetes mellitus induced by megestrol acetate in a patient with AIDS and cachexia. Ann Intern Med. 1992;116:53-4.
29. Ott M, Lembcke B, Fischer H, Jager R, Polat H, Geier H, et al. Early changes of body composition in human immunodeficiency virus-infected patients: tetrapolar body impedance analysis indicates significant malnutrition. Am J Clin Nutr. 1993;57:15-9.